Mirum Pharmaceuticals, Inc. ( MIRM) - Key Metrics
MIRM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $2.78 | -$1.06 | -$4.31 | -$4.32 |
| 2026Q1 | $2.72 | -$13.43 | -$3.89 | -$3.90 |
| 2025Q4 | $2.97 | -$0.11 | $0.12 | $0.11 |
| 2025Q3 | $2.29 | $0.05 | $0.68 | $0.68 |
| 2025Q2 | $2.57 | -$0.12 | $0.24 | $0.24 |
MIRM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -27.61 |
| 2026Q1 | 0% | -1.72 |
| 2025Q4 | 0% | -164.56 |
| 2025Q3 | 0% | 319.29 |
| 2025Q2 | 0% | -106.02 |
MIRM
Price: $100.64
52 week price:
Earnings Per Share: -13.81 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 266732
Market Capitalization: 6.0 billion